e08019@excelsior.com.tw

Announcement to correct the company’s statements of endorsements and guarantees in November 2023.

  SEQ_NO  2 Date of announcement 2024/01/10 Time of announcement 17:04:04 Subject Announcement to correct the company’s statements of endorsements and guarantees in November 2023. Date of events  2024/01/10 To which item it meets paragraph 51 Statement 1.Date of occurrence of the event:2024/01/10 2.Company name:Excelsior Medical Co.,Ltd 3.Relationship with the Company (please enter ”the company …

Announcement to correct the company’s statements of endorsements and guarantees in November 2023. Read More »

Announcement on behalf of major subsidiary, Excelsior Asset Management Co., Ltd., regarding the change of general manager.

  SEQ_NO  3 Date of announcement 2023/12/29 Time of announcement  17:38:06 Subject Announcement on behalf of major subsidiary, Excelsior Asset Management Co., Ltd., regarding the change of general manager. Date of events 2023/12/29 To which item it meets paragraph 6 Statement 1.Date of the board of directors resolution or date of occurrence of the change: …

Announcement on behalf of major subsidiary, Excelsior Asset Management Co., Ltd., regarding the change of general manager. Read More »

To announce the change of deputy general manager of the company.

  SEQ_NO  2 Date of announcement 2023/12/29 Time of announcement 17:37:28 Subject To announce the change of deputy general manager of the company. Date of events 2023/12/29 To which item it meets paragraph 8 Statement 1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, corporate …

To announce the change of deputy general manager of the company. Read More »

To announce the change of acting spokesperson of the company.

  SEQ_NO  1 Date of announcement 2023/12/29 Time of announcement 17:36:38 Subject To announce the change of acting spokesperson of the company. Date of events 2023/12/29 To which item it meets paragraph 8 Statement 1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, corporate governance …

To announce the change of acting spokesperson of the company. Read More »

The Board of Directors approved Q3 2023 consolidated financial statements.

  SEQ_NO  1 Date of announcement 2023/11/07 Time of announcement 18:07:38 Subject The Board of Directors approved Q3 2023 consolidated financial statements. Date of events 2023/11/07 To which item it meets paragraph 31 Statement 1.Date of submission to the board of directors or approval by the board of directors:2023/11/07 2.Date of approval by the audit …

The Board of Directors approved Q3 2023 consolidated financial statements. Read More »